American College of Cardiology

JACC Global

Health EN ↓ 95 episodes

Explore cardiovascular science from a global perspective with JACC Global. This podcast highlights original research, regional innovations, and urgent challenges in heart health across diverse healthcare settings worldwide.

Be sure to visit the podcast's website and support the creator: www.jacc.org

Author

American College of Cardiology

Category

Health

Podcast website

www.jacc.org

Latest episode

Nov 17, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

Does Tafamidis Attenuate the Benefits of Vutrisiran in ATTR-CM? | JACC Baran 17.11.2026

Does adding a gene silencer to a TTR stabiliser provide additional benefit in transthyretin amyloid cardiomyopathy (ATTR-CM)? Host Mitsuaki Sawano, MD, and co-host Nobuhiro Ikemura, MD, welcome Yasuhiro Hamatani, MD, PhD (Brigham and Women's Hospital, Harvard Medical School) to discuss his JACC study, published simultaneously with ESC 2026, examining vutrisiran efficacy according to baseline tafam...

Angiography-Derived FFR: Can We Guide PCI Without a Pressure Wire? | JACC Baran 10.11.2026

Can we make reliable PCI decisions based on coronary angiography alone? Host Mitsuaki Sawano, MD, welcomes Toru Tanigaki, MD (Gifu Heart Center), Takuya Mizukami, MD, PhD (Showa Medical University), and Hitoshi Matsuo, MD, PhD (Gifu Heart Center) to discuss their recent JACC: Cardiovascular Interventions study. The investigator-initiated PROVISION trial randomised 401 patients across 13 Japanese c...

ICI Myocarditis: Does Timing Define the Disease? | JACC Baran 03.11.2026

Is immune checkpoint inhibitor (ICI)-associated myocarditis the same disease when it occurs early versus months after starting cancer therapy? Host Mitsuaki Sawano, MD, and co-host Shun Kohsaka, MD, welcome Kazuaki Maruyama, MD (Mie University), Shiro Nakamori, MD (Mie University), and Yuichi Tamura, MD (International University of Health and Welfare) to discuss their recent JACC: CardioOncology s...

ICI Myocarditis: Does Timing Define the Disease? | JACC Baran 03.11.2026

Is immune checkpoint inhibitor (ICI)-associated myocarditis the same disease when it occurs early versus months after starting cancer therapy? Host Mitsuaki Sawano, MD, and co-host Shun Kohsaka, MD, welcome Kazuaki Maruyama, MD (Mie University), Shiro Nakamori, MD (Mie University), and Yuichi Tamura, MD (International University of Health and Welfare) to discuss their recent JACC: CardioOncology s...

Does PFA Reach the Vein of Marshall? | JACC Baran 27.10.2026

Does pulsed field ablation (PFA) for pulmonary vein isolation affect structures beyond the pulmonary veins? Host Mitsuaki Sawano, MD, welcomes Yosuke Nakatani, MD (Gunma University) to discuss his recent JACC: Clinical Electrophysiology study examining the effects of PFA on the vein of Marshall (VoM). In this prospective study of 72 patients undergoing PFA using three different systems, a microele...

A SELUTION to Paclitaxel DCB Complications in PAD? | JACC Baran Video 20.10.2026

Could sirolimus-coated balloons change how we treat femoropopliteal peripheral artery disease? Host Mitsuaki Sawano, MD, welcomes Yoshimitsu Soga, MD, PhD (Kokura Memorial Hospital) to discuss the 3-year results of the SELUTION SFA Japan study, a prospective multicenter study of 134 patients with symptomatic femoropopliteal disease treated with a novel sirolimus-eluting balloon. Despite relatively...

Proteomics in Action: Finding the Right Drug Targets for Ischemic Heart Disease | JACC Baran 13.10.2026

Which of the thousands of biomarkers associated with cardiovascular disease could actually become a useful drug target? Host Mitsuaki Sawano, MD, and co-host Nobuhiro Ikemura, MD, welcome Satoshi Yoshiji, MD, PhD (McGill University) to discuss a recent JACC study tackling this question in ischemic heart disease. Starting with 9,520 circulating proteins, the investigators used human genetics to mov...

PET Unmasks CMD: The Hidden Risk Behind Normal Perfusion | JACC Baran 06.10.2026

Hosts Mitsuaki Sawano, MD, Satoshi Shoji, MD, and Kentaro Ejiri, MD, welcome Yoshito Kadoya, MD, PhD (University of British Columbia / St. Paul’s Hospital) to discuss his JACC: Cardiovascular Imaging study, “PET-Based Coronary Microvascular Dysfunction Phenotypes and Outcomes in Patients With Normal Myocardial Perfusion.” Among 3,317 patients with normal relative perfusion on cardiac PET, the stud...

Rethinking Health Care at Home and Abroad: Lancet RH Western Pacific Special | JACC Baran 29.09.2026

Host Mitsuaki Sawano, MD, welcomes Shuhei Nomura, PhD (Tohoku University), Lisa Yamasaki, MD (Harvard T.H. Chan School of Public Health), and Haruka Sakamoto, MD, PhD (St. Luke’s International Hospital) to discuss two policy reviews published in The Lancet Regional Health – Western Pacific. Fifteen years after the 2011 Lancet Japan Series, Japan faces population aging, rising long-term care needs,...

PFA Changes the Game and the AT Circuit | JACC Baran 22.09.2026

Hosts Mitsuaki Sawano, MD, and Hiroyuki Sato, MD, welcome Kazutaka Nakasone, MD (Kobe University) to discuss his JACC: Clinical Electrophysiology study on atrial tachycardia (AT) after pulsed field ablation (PFA) for atrial fibrillation. In a 5-center European registry of 4,144 patients, 76 (1.8%) underwent repeat ablation for AT. Most ATs were left atrial macroreentrant tachycardias, with approxi...

Is “Normal” Hemoglobin Really Normal in Heart Failure? | JACC Baran 15.09.2026

Hosts Mitsuaki Sawano, MD, and Satoshi Shoji, MD, welcome Misato Chimura, MD, PhD (University of Glasgow) to discuss her ESC SimPub paper in JACC, “Low-normal hemoglobin concentrations and clinical outcomes in heart failure.” Using individual participant-level data from 11 randomized trials including 42,213 patients across the full LVEF spectrum, the study examined the continuous relationship betw...

BRIDGING the Lipid Management Gap After ACS: ESC Late-Breaker | JACC Baran 09.09.2026

Hosts Mitsuaki Sawano, MD, and Shun Kohsaka, MD, welcome Kazuma Ohyama, MD, PhD (Tohoku University) to discuss the BRIDGE trial, Protocol-Based Implementation of Early Intensive Lipid Management After Acute Coronary Syndrome. In this 10-center cluster-randomized trial, hospitals were assigned to either protocol-based or standard lipid management after emergency PCI for ACS. Rather than simply remi...

ESC 2026 Special: JACC SimPub Papers You Should Know | JACC Baran 01.09.2026

Hosts Mitsuaki Sawano, MD, Takeshi Kitai, MD, PhD, Kentaro Ejiri, MD, PhD, and Satoshi Shoji, MD, PhD, highlight three JACC papers presented at ESC 2026 and simultaneously published with the meeting. Dr. Kitai discusses new HELIOS-B insights on whether the benefits of vutrisiran in transthyretin amyloidosis with cardiomyopathy are maintained among patients already receiving tafamidis. Dr. Ejiri re...

The Lancet: OPTIMA-AF, Is 1 Month Enough After PCI? | JACC Baran 25.08.2026

Hosts Mitsuaki Sawano, MD, Shun Kohsaka, MD, Nobuhiro Ikemura, MD, and Satoshi Shoji, MD, welcome Yohei Sotomi, MD, PhD (The University of Osaka), and Ken Kozuma, MD, PhD (Teikyo University) for a special episode made possible through the JACC–Lancet partnership to discuss the OPTIMA-AF trial, published in The Lancet. In this investigator-initiated, multicenter randomized trial of 1,079 patients w...

HFpEF: Why Earlier May Be Better | JACC Baran 18.08.2026

Hosts Mitsuaki Sawano, MD, Nobuhiro Ikemura, MD, and Satoshi Shoji, MD welcome Shunichi Doi, MD (St. Marianna University School of Medicine) to discuss his JACC: Heart Failure study, Heart Failure Duration, Cardiac Remodeling, Dysfunction, and Hemodynamic Severity in HFpEF and HFmrEF: Insights From REDUCE LAP-HF II. In this prespecified subanalysis of the REDUCE LAP-HF II trial, 522 patients with...

Post-PCI Hematoma: What IVUS Tells Us | JACC Baran 11.08.2026

Percutaneous coronary intervention (PCI) is safer than ever, yet coronary hematoma remains an underrecognized cause of early ischemic complications. In this episode, Host Mitsuaki Sawano, MD welcome Takunori Tsukui, MD and Akiko Maehara, MD to discuss their JACC: Cardiovascular Interventions study comparing 22 event-causing hematomas with 80 event-free hematomas identified from more than 3,000 IVU...

Pediatric Heart Transplantation: When Priority Doesn't Match Urgency | JACC Baran 04.08.2026

Pediatric heart transplantation is one of medicine's scarcest resources, where every allocation decision can mean the difference between life and death. But does the current system truly prioritize the children at greatest risk? Hosts Mitsuaki Sawano, MD, and Satoshi Shoji, MD welcome Kazunari Sasaki, MD (Stanford University) to discuss his JACC study, Status Exceptions and Misalignment of Medical...

PACs: Benign Bystanders or AF in Disguise? | JACC Baran 28.07.2026

Premature atrial complexes (PACs) are among the most common arrhythmias encountered in daily practice and are often dismissed as benign. But are they truly harmless—or could some represent the earliest stage of atrial fibrillation (AF)? Hosts Mitsuaki Sawano, MD, and Hiroyuki Sato, MD welcome Satoshi Higuchi, MD (Tokyo Women's Medical University) to discuss his JACC: Clinical Electrophysiology stu...

Cancer VTE + DOAC: Who Will Bleed? | JACC Baran 21.07.2026

Patients with active cancer face a difficult balance: preventing recurrent venous thromboembolism while avoiding major bleeding during anticoagulation. But which patients are truly at highest bleeding risk? Hosts Mitsuaki Sawano, MD welcome Tomoyuki Nagai, MD (Kyoto Prefectural University of Medicine) and Naohiko Nakanishi, MD (Kyoto Prefectural University of Medicine) to discuss their JACC: Cardi...

HFpEF Without Obesity: What Coronary Microcirculation Tells Us | JACC Baran 14.07.2026

Host Mitsuaki Sawano, MD, welcomes Kai Nogami, MD (Mayo Clinic), to discuss his JACC Brief Report, "Higher Prevalence of Coronary Microvascular Dysfunction in Patients With HFpEF Without Obesity." Why do some patients develop HFpEF despite not being obese? In this episode, Dr. Nogami explains how combining invasive coronary function testing with exercise hemodynamics revealed a remarkably high pre...

What Autopsy Reveals About MINOCA and Sudden Cardiac Death | JACC Baran 07.07.2026

Hosts Mitsuaki Sawano, MD, Kentaro Ejiri, MD, Hiroyuki Sato, MD, and Shun Kosaka, MD welcome Dr. Kosuke Nakasuka, MD, PhD to discuss his JACC study, Sudden Cardiac Death Due to Myocardial Infarction With Obstructive and Nonobstructive Coronary Arteries. Using one of the world's most comprehensive population-based autopsy cohorts, this study challenges a decades-old assumption that myocardial infar...

Remnant Cholesterol: Small Name, Big ASCVD Risk | JACC Baran 30.06.2026

Hosts Mitsuaki Sawano, MD, Nobuhiro Ikemura, MD, and Satoshi Shoji, MD welcome Takahito Doi, MD, PhD to discuss his JACC Brief Report, “Risk of Atherosclerotic Cardiovascular Disease in Familial Remnant Hyperlipidemia and Familial Hypercholesterolemia.” Using prospective population cohorts from Copenhagen and the UK Biobank, this study examined whether familial remnant hyperlipidemia, historically...

Post-AF Ablation Anticoagulation: How Long Is Long Enough? | JACC Baran 23.06.2026

Hosts Mitsuaki Sawano, MD, Kentaro Ejiri, MD, and Hiroyuki Sato, MD welcome Tomoya Iwawaki, MD and Satoshi Yanagisawa, MD to discuss their JACC: Clinical Electrophysiology study, “Optimal Timing for Oral Anticoagulant Discontinuation and Prognosis After Successful Catheter Ablation for Atrial Fibrillation.” Using data from 2,448 patients undergoing first-time AF ablation, the investigators perform...

Ultra-Low-Dose CAC in the Photon-Counting Era | JACC Baran 16.06.2026

Hosts Mitsuaki Sawano, MD, and Shun Kohsaka, MD welcome Dr. Suguru Araki, MD and Dr. Satoshi Nakamura, MD (Mie University) to discuss their JACC: Cardiovascular Imaging study, “Validation of Ultra-Low-Dose Coronary Artery Calcium Scoring Using Photon-Counting Computed Tomography.” As cardiac CT becomes increasingly central to cardiovascular diagnosis and prevention, radiation exposure remains an i...

The Rise of PROs: What Traditional Risk Scores May Be Missing | JACC Baran 09.06.2026

Hosts Mitsuaki Sawano, MD, and Satoshi Shoji, MD welcome Dr. Kazuya Nagao, MD (Kyoto University) to discuss his JACC: Heart Failure study, “Multidimensional Patient-Reported Outcomes in Acutely Decompensated Heart Failure: Prognostic Implications in a Real-World Cohort.” Using JROADHF-NEXT, this study examined three different PRO tools—KCCQ, EQ-5D-5L LSS, and PHQ-9—in patients hospitalized with ac...

Listen to the JACC Global podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.